6 completed. 5 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 1 | 2 | Completed 2 |
Follow ALX-0061: new trials by email Literature Review of ALX-0061 trials Research Report on ALX-0061
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus ALX-0061, Placebo - Lupus Erythematosus, Systemic | Phase 2 | Completed | Ablynx, a Sanofi company | 312 | 2015-07-01 | 2019-02-26 |
| An Open-Label Extension Study Assessing the Long-Term Efficacy and Safety of ALX-0061 in Subjects With Rheumatoid Arthritis ALX-0061 - Rheumatoid Arthritis | Phase 2 | Completed | Ablynx, a Sanofi company | 406 | 2015-07-01 | 2019-07-30 |
| A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis ALX-0061, Placebo, Tocilizumab - Rheumatoid Arthritis | Phase 2 | Completed | Ablynx, a Sanofi company | 251 | 2015-03-01 | 2019-08-21 |
| A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis ALX-0061, Placebo, Methotrexate - Rheumatoid Arthritis | Phase 2 | Completed | Ablynx, a Sanofi company | 345 | 2015-01-01 | 2019-08-21 |
| ALX-0061 Phase I Bioavailability Study in Healthy Volunteers ALX-0061 - Rheumatoid Arthritis | Phase 1 | Completed | Ablynx, a Sanofi company | 70 | 2014-03-31 | 2019-01-04 |
| Study to Assess Safety and Efficacy of Anti-Interleukin 6-receptor (IL6R) Nanobody in Rheumatoid Arthritis (RA) Patients ALX-0061, Placebo - Rheumatoid Arthritis | Phase 1 / Phase 2 | Completed | Ablynx, a Sanofi company | 65 | 2011-03-01 | 2019-01-04 |
Arthritis, Rheumatoid (5) · Lupus Erythematosus, Systemic (1)
Hungary (5) · Poland (5) · Czechia (4) · Germany (4) · Mexico (4) · Serbia (4) · Spain (4) · Belgium (3) · Bulgaria (3) · Georgia (3) · Moldova (3) · North Macedonia (3) · Romania (3) · United States (3) · Argentina (1)
Josefin-Beate Holz, MD (1) · Steven De Bruyn, MD (1)
2014 (3), 2015 (1)